In addition to the resources we dedicate to supporting your next breakthrough product, Grace’s FCMS maintains an ongoing program to develop new APIs for several therapeutic indications.
View our generic portfolio and discover how we can support you by optimizing our APIs for use in a wide range of dosage forms.
See the Portfolio